Jpmorgan Chase & CO Biom X Inc. Transaction History

Jpmorgan Chase & CO

  • $1.22 Trillion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022
SELL
$6.4 - $20.2 $3,872 - $12,221
-605 Closed
0 $0
Q1 2022

May 11, 2022
BUY
$12.1 - $20.6 $7,320 - $12,463
605 New
605 $1,000

Others Institutions Holding PHGE

# of Institutions
2
Shares Held
301K
Call Options Held
0
Put Options Held
0
View Full List

About BiomX Inc.

PHGE Quotes by TradingView
  • Ticker PHGE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,982,300
  • Market Cap $19.5M
  • Description
  • BiomX Inc., a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibr...
More about PHGE
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email